KC
Kryger Capital Portfolio holdings
AUM
$1.75B
Turnover
75%
1-Year Est. Return
102.57%
This Fund
S&P 500
This Quarter
Est. Return
+11.9%
1 Year Est. Return
+102.57%
3 Year Est. Return
+420.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.75B
AUM Growth
+$339M
(+24%)
Cap. Flow
+$244M
Cap. Flow
% of AUM
13.93%
Top 10 Holdings %
Top 10 Hldgs %
74.92%
Holding
148
New
72
Increased
20
Reduced
17
Closed
39
Avg Time Held
0.1
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$72.8M |
| 2 |
Chart Industries
GTLS
|
+$71.1M |
| 3 |
Apogee Therapeutics
APGE
|
+$66.9M |
| 4 |
AES
AES
|
+$66.7M |
| 5 |
Kenvue
KVUE
|
+$58.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clearwater Analytics
CWAN
|
+$90.3M |
| 2 |
Day One Biopharmaceuticals
DAWN
|
+$83.5M |
| 3 |
Amicus Therapeutics
FOLD
|
+$65.9M |
| 4 |
Hologic
HOLX
|
+$62.1M |
| 5 |
Air Lease Corp
AL
|
+$57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.67% |
| 2 | Financials | 22.06% |
| 3 | Communication Services | 18.07% |
| 4 | Healthcare | 12.34% |
| 5 | Consumer Staples | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Norfolk Southern
NSC
$72.8B
| $241M | 13.75% |
766,243
+235,974
| +45% | +$72.8M |
2025 Q3
3 quarters
|
|
|
2
DELISTED
Chart Industries
GTLS
| $186M | 10.64% |
892,579
+342,462
| +62% | +$71.1M |
2025 Q3
3 quarters
|
|
|
3
Kenvue
KVUE
$34.6B
| $163M | 9.32% |
8,549,767
+3,338,653
| +64% | +$58.8M |
2025 Q4
2 quarters
|
|
4
DELISTED
DigitalBridge
DBRG
| $142M | 8.1% |
9,002,375
+2,339,866
| +35% | +$36.6M |
2025 Q4
2 quarters
|
|
5
DELISTED
Electronic Arts
EA
| $141M | 8.03% |
686,759
+178,500
| +35% | +$36.2M |
2025 Q4
2 quarters
|
|
6
DELISTED
Warner Bros
WBD
| $111M | 6.34% |
4,170,929
+1,084,098
| +35% | +$29.3M |
2025 Q4
2 quarters
|
|
|
7
AES
AES
$10.7B
| $100M | 5.72% |
6,840,535
+4,590,535
| +204% | +$66.7M |
2026 Q1
1 quarter
|
|
|
8
DELISTED
Apogee Therapeutics
APGE
| $98.6M | 5.62% |
+742,555
| New | +$66.9M |
2026 Q2
0 quarters
|
|
9
Silicon Laboratories
SLAB
$7.38B
| $71.9M | 4.1% |
329,090
+149,703
| +83% | +$32.4M |
2026 Q1
1 quarter
|
|
10
Roku
ROKU
$22.7B
| $57.4M | 3.27% |
+415,486
| New | +$50.7M |
2026 Q2
0 quarters
|
|
11
Brighthouse Financial
BHF
$2.75B
| $48.7M | 2.78% |
769,937
+267,203
| +53% | +$16.6M |
2025 Q3
3 quarters
|
|
12
DELISTED
Nuvalent
NUVL
| $35.4M | 2.02% |
+286,712
| New | +$30.8M |
2026 Q2
0 quarters
|
|
13
Penumbra
PEN
$12.6B
| $33.9M | 1.93% |
107,207
-46,641
| -30% | -$15.1M |
2026 Q1
1 quarter
|
|
14
Caesars Entertainment
CZR
$5.97B
| $29.2M | 1.66% |
+966,906
| New | +$27.3M |
2026 Q2
0 quarters
|
|
15
Organon & Co
OGN
$3.61B
| $29.1M | 1.66% |
+2,152,693
| New | +$25.7M |
2026 Q2
0 quarters
|
|
16
Bio-Techne
TECH
$11.4B
| $19.4M | 1.11% |
+274,290
| New | +$14.8M |
2026 Q2
0 quarters
|
|
17
Lafayette Digital Acquisition Corp I
ZKP
$392M
| $15.9M | 0.91% |
1,594,970
-27,161
| -2% | -$269K |
2026 Q1
1 quarter
|
|
18
Mountain Lake Acquisition Corp II
MLAA
| $12.6M | 0.72% |
+1,270,887
| New | +$12.7M |
2026 Q2
0 quarters
|
|
19
Translational Development Acquisition Corp
TDAC
$209M
| $12.2M | 0.7% |
+1,141,050
| New | +$12.2M |
2026 Q2
0 quarters
|
|
20
Illumination Acquisition Corp I
ILLU
| $9.78M | 0.56% |
+988,182
| New | +$9.77M |
2026 Q2
0 quarters
|
|
21
Activate Energy Acquisition Corp
AEAQ
$316M
| $8.62M | 0.49% |
861,748
-57,825
| -6% | -$577K |
2026 Q1
1 quarter
|
|
22
Abony Acquisition Corp I
AACO
$313M
| $8.32M | 0.47% |
+839,955
| New | +$8.31M |
2026 Q2
0 quarters
|
|
23
Aldabra 4 Liquidity Opportunity Vehicle
ALOV
$376M
| $7.41M | 0.42% |
+745,106
| New | +$7.38M |
2026 Q2
0 quarters
|
|
24
Legato Merger Corp IV
LEGO
| $7.4M | 0.42% |
+745,858
| New | +$7.38M |
2026 Q2
0 quarters
|
|
25
Skydance Corporation
SKYD
$35.5B
| $7.39M | 0.42% |
+1,498,698
| New | +$7.89M |
2026 Q2
0 quarters
|
|
Similar funds
L7C
SB
FTS
PIM
RCW
AG
KC
ACG
Kryger Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Kryger Capital held 148 positions worth $1.75B, up 24% from $1.41B the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Kryger Capital deployed $244M of net new capital in Q2 2026, opening 72 new positions and adding to 20 existing holdings. Its largest new stake was Apogee Therapeutics: 742,555 shares worth $98.6M.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Penumbra, an estimated $15.1M trimmed.
- Kryger Capital's largest Q2 2026 buy was Apogee Therapeutics: 742,555 shares worth $98.6M.
- Kryger Capital added most to Norfolk Southern in Q2 2026, an estimated $72.8M increase.
- Kryger Capital's biggest Q2 2026 reduction was Penumbra, cutting an estimated $15.1M.
- Kryger Capital fully exited Clearwater Analytics in Q2 2026, selling an estimated $90.3M.
- Kryger Capital's ten largest holdings make up 75% of its $1.75B portfolio in Q2 2026.
- Kryger Capital opened 72 new positions and closed 39 in Q2 2026.
- Kryger Capital's portfolio value rose 24% quarter-over-quarter to $1.75B.
Based on Kryger Capital's 13F filing for Q2 2026, filed 14 Aug 2026.